Posted by Michael Wonder on 18 Oct 2021
New asthma drug approved on NHS branded a ‘wonder drug’
18 October 2021 - NICE has issued a Final Appraisal Determination recommending dupilumab as an add-on maintenance treatment for severe asthma.
Dupilumab (Dupixent) will be available to patients through injections. These injections are given every few weeks, and were shown in clinical trials to reduce the frequency of asthma attacks when combined with standard inhalers.
